World Alzheimer Report 2022: Life after diagnosis: Navigating treatment, care and support.
2022
World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia.
10.1002/alz.12123 · 2020
A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial.
10.1016/s0140-6736(15)60461-5 · 2015
Association of the Mediterranean Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) diet with the risk of dementia.
2023
Accelerometer-determined physical activity and cognitive function in middle-aged and older adults from two generations of the Framingham Heart Study
2019
Effects of daily matcha and caffeine intake on mild acute psychological stress-related cognitive function in middle-aged and older adults: A Randomized Placebo-Controlled Study.
2021
Matcha consumption maintains attentional function following a mild acute psychological stress without affecting a feeling of fatigue: A randomized placebo-controlled study in young adults.
10.1016/j.nutres.2020.12.024 · 2021
The effects of L-theanine (Suntheanine®) on objective sleep quality in boys with attention deficit hyperactivity disorder (ADHD): a randomized, double-blind, placebo-controlled clinical trial.
2011
Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice.
10.1016/j.brainres.2008.02.107 · 2008
Anti-stress effects of drinking green tea with lowered caffeine and enriched theanine, epigallocatechin and arginine on psychosocial stress induced adrenal hypertrophy in mice.
10.1016/j.phymed.2016.07.006 · 2016
Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project
10.1093/ajcn/83.2.355 · 2006
Total phenol, catechin, and caffeine contents of teas commonly consumed in the United kingdom
10.1021/jf010153l · 2002
Effects of matcha green tea powder on cognitive functions of community-dwelling elderly individuals.
2020
Prevalence of sleep disturbance and hypnotic medication use in relation to sociodemographic factors in the general Japanese adult population.
10.2188/jea.10.79 · 2000
An epidemiological study of insomnia among the Japanese general population.
2000
Unresolved referenced work
2006
β-Amyloid accumulation in the human brain after one night of sleep deprivation
10.1073/pnas.1721694115 · 2018
Implications of sleep disturbance and inflammation for Alzheimer’s disease dementia
10.1016/s1474-4422(18)30450-2 · 2019
Association of sleep duration in middle and old age with incidence of dementia.
10.1038/s41467-021-22354-2 · 2021
Prediction of longitudinal cognitive decline in preclinical Alzheimer Disease using plasma biomarkers
2023
Alpha-2 macroglobulin in Alzheimer’s disease: a marker of neuronal injury through the RCAN1 pathway
10.1038/mp.2016.206 · 2017
Association between serum concentrations of apolipoprotein A-I (apoA-I) and Alzheimer’s disease: Systematic Review and Meta-Analysis.
10.3390/diagnostics11060984 · 2021
An updated Alzheimer hypothesis: Complement C3 and risk of Alzheimer’s disease—A cohort study of 95,442 individuals.
10.1016/j.jalz.2018.07.223 · 2018
Plasma transthyretin as a candidate marker for Alzheimer’s disease
10.3233/jad-2011-110611 · 2012
Plasma transthyretin as a predictor of amnestic mild cognitive impairment conversion to dementia.
10.1038/s41598-019-55318-0 · 2019
Serum albumin concentration and cognitive impairment.
10.2174/156720510790274392 · 2010
Amyloid-β sequester proteins as blood-based biomarkers of cognitive decline
10.1016/j.dadm.2015.04.003 · 2015
Serum levels of proteins involved in amyloid-β clearance are related to cognitive decline and neuroimaging changes in mild cognitive impairment
2019
Effectiveness of nonpharmacological approaches in patients with mild cognitive impairment.
10.1159/000320575 · 2011
The effects of an aerobic and resistance exercise training program on cognition following stroke
10.1177/1545968312465192 · 2013
The effectiveness of a cognitive training program in people with mild cognitive impairment: A study in urban community.
10.1016/j.ajp.2018.04.028 · 2018
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
10.1016/s0140-6736(20)30367-6 · 2020
Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial
10.2307/2529712 · 1975
Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis.
10.1111/acps.12336 · 2014
Subjective cognitive decline: Level of risk for future dementia and mild cognitive impairment, a meta-analysis of longitudinal studies.
10.1007/s11065-021-09522-3 · 2022
Implementation of subjective cognitive decline criteria in research studies.
10.1016/j.jalz.2016.09.012 · 2017
Clinical usefulness of CNS vital signs for assessing neurocognition in ADHD.
2007
Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs.
10.1016/j.acn.2006.05.007 · 2006
An inventory to assess activities of daily living for clinical trials in Alzheimer’s disease. The Alzheimer’s Disease Cooperative Study
1997
ADCS prevention instrument project: Assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials.
10.1097/01.wad.0000213873.25053.2b · 2006
